Differential effects of NOD2 polymorphisms on colorectal cancer risk: A meta-analysis

International Journal of Colorectal Disease

Volumn 25, Issue 2, 2010, Pages 161-168

  Tian, Yun ^a   Li, Yi ^b   Hu, Zhenhua ^c   Wang, Daqing ^a   Sun, Xiyang ^a   Ren, Changshan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Colorectal cancer; NOD2 CARD15; Polymorphism

Indexed keywords

ARGININE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; GLYCINE; PROLINE; SERINE; TRYPTOPHAN;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CAUCASIAN; COLORECTAL CANCER; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; PRIORITY JOURNAL; SYSTEMATIC REVIEW; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; ODDS RATIO; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 77649237093     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0809-9     Document Type: Article

References (64)

1. G Capurso M Marignani G Delle Fave 2006 Probiotics and the incidence of colorectal cancer: when evidence is not evident Dig Liver Dis 38 Suppl 2 S277 S282 10.1016/S1590-8658(07)60010-3 17259091 (Pubitemid 46140769)
2. HJ Kim MH Yu H Kim J Byun C Lee 2008 Noninvasive molecular biomarkers for the detection of colorectal cancer BMB Rep 41 685 692 1:CAS:528: DC%2BD1cXhtlyqsr7K 18959813
3. I Loffler M Grun FD Bohmer I Rubio 2008 Role of cAMP in the promotion of colorectal cancer cell growth by prostaglandin E2 BMC Cancer 8 380 10.1186/1471-2407-8-380 19099561
4. H Takahashi M Inamori 2009 Lifestyle-related disease and colorectal cancer Intern Med 48 121 10.2169/internalmedicine.48.1800 19182420
5. B Kasztelan-Szczerbinska H Cichoz-Lach M Slomka 2008 Colorectal cancer as a health care problem: evaluation of the current diagnostic options Pol Arch Med Wewn 118 224 227 18575422
6. VE Velculescu 2008 Defining the blueprint of the cancer genome Carcinogenesis 29 1087 1091 10.1093/carcin/bgn096 1:CAS:528:DC%2BD1cXot1Wjtrs%3D 18495658 (Pubitemid 351958685)
7. IM Hisamuddin VW Yang 2004 Genetics of colorectal cancer MedGenMed 6 13 15520636
8. PY Cheah 2009 Recent advances in colorectal cancer genetics and diagnostics Crit Rev Oncol Hematol 69 45 55 10.1016/j.critrevonc.2008.08.001 18774731
9. E Chu 2009 Clinical colorectal cancer: "2008-the year in review" Clin Colorectal Cancer 8 9 10 10.3816/CCC.2009.n.001 19203890
10. J Hampe A Cuthbert PJ Croucher MM Mirza S Mascheretti S Fisher, et al. 2001 Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations Lancet 357 1925 1928 10.1016/S0140-6736(00)05063- 7 1:CAS:528:DC%2BD3MXks1OisLk%3D 11425413 (Pubitemid 32568333)
11. JP Hugot M Chamaillard H Zouali S Lesage JP Cezard J Belaiche, et al. 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 599 603 10.1038/35079107 1:CAS:528: DC%2BD3MXksVShtLY%3D 11385576 (Pubitemid 32531408)
12. Y Ogura DK Bonen N Inohara DL Nicolae FF Chen R Ramos, et al. 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 603 606 10.1038/35079114 1:CAS:528:DC%2BD3MXksVShur8%3D 11385577 (Pubitemid 32531409)
13. C Inohara C McDonald G Nunez 2005 NOD-LRR proteins: role in host-microbial interactions and inflammatory disease Annu Rev Biochem 74 355 383 10.1146/annurev.biochem.74.082803.133347 1:CAS:528:DC%2BD2MXpsVens7Y%3D 15952891 (Pubitemid 40995511)
14. SE Girardin IG Boneca J Viala M Chamaillard A Labigne G Thomas, et al. 2003 Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection J Biol Chem 278 8869 8872 10.1074/jbc.C200651200 1:CAS:528: DC%2BD3sXhvVyqsbs%3D 12527755 (Pubitemid 36800360)
15. N Inohara G Nunez 2001 The NOD: a signaling module that regulates apoptosis and host defense against pathogens Oncogene 20 6473 6481 10.1038/sj.onc.1204787 1:CAS:528:DC%2BD3MXnvVegsbw%3D 11607846 (Pubitemid 32977852)
16. N Inohara Y Ogura A Fontalba O Gutierrez F Pons J Crespo, et al. 2003 Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease J Biol Chem 278 5509 5512 10.1074/jbc. C200673200 1:CAS:528:DC%2BD3sXht1aqsro%3D 12514169 (Pubitemid 36800790)
17. SE Girardin R Tournebize M Mavris AL Page X Li GR Stark, et al. 2001 CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri EMBO Rep 2 736 742 10.1093/embo-reports/kve155 1:CAS:528:DC%2BD3MXmt1OqtL4%3D 11463746 (Pubitemid 32798718)
18. S Angeletti S Galluzzo D Santini A Ruzzo B Vincenzi E Ferraro, et al. 2009 NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population Hum Immunol 70 9 729 732 10.1016/j.humimm.2009.04.026 1:CAS:528:DC%2BD1MXhtVarur7L 19397946
19. JR Jackson MP Seed CH Kircher DA Willoughby JD Winkler 1997 The codependence of angiogenesis and chronic inflammation FASEB J 11 457 465 1:CAS:528:DyaK2sXjvFahsb8%3D 9194526
20. M Jaiswal NF LaRusso LJ Burgart GJ Gores 2000 Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism Cancer Res 60 184 190 1:CAS:528: DC%2BD3cXnt1antQ%3D%3D 10646872
21. N Nakajima H Kuwayama Y Ito A Iwasaki Y Arakawa 1997 Helicobacter pylori, neutrophils, interleukins, and gastric epithelial proliferation J Clin Gastroenterol 25 Suppl 1 S198 S202 10.1097/00004836-199700001-00031 9479648 (Pubitemid 28117028)
22. CN Bernstein JF Blanchard E Kliewer A Wajda 2001 Cancer risk in patients with inflammatory bowel disease: a population-based study Cancer 91 854 862 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z 1:STN:280:DC%2BD3M3hsFWluw%3D%3D 11241255 (Pubitemid 32173312)
23. T Jess M Gamborg P Matzen P Munkholm TI Sorensen 2005 Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies Am J Gastroenterol 100 2724 2729 10.1111/j.1572-0241.2005.00287.x 16393226 (Pubitemid 43919641)
24. E Leshinsky-Silver A Karban E Buzhakor M Fridlander B Yakir R Eliakim, et al. 2005 Is age of onset of Crohn's disease governed by mutations in NOD2/caspase recruitment domains 15 and Toll-like receptor 4? Evaluation of a pediatric cohort Pediatr Res 58 499 504 10.1203/01.PDR.0000175640.75468.D6 1:CAS:528:DC%2BD2MXpsFymsr8%3D 16148063 (Pubitemid 41254514)
25. P Alhopuro T Ahvenainen JP Mecklin M Juhola HJ Jarvinen A Karhu, et al. 2004 NOD2 3020insC alone is not sufficient for colorectal cancer predisposition Cancer Res 64 7245 7247 10.1158/0008-5472.CAN-04-2364 1:CAS:528: DC%2BD2cXosFynt70%3D 15492242 (Pubitemid 39372060)
26. G Kurzawski J Suchy J Kladny E Grabowska M Mierzejewski A Jakubowska, et al. 2004 The NOD2 3020insC mutation and the risk of colorectal cancer Cancer Res 64 1604 1606 10.1158/0008-5472.CAN-03-3791 1:CAS:528:DC%2BD2cXhsl2iur4%3D 14996717 (Pubitemid 38428679)
27. PL Lakatos E Hitre F Szalay K Zinober P Fuszek L Lakatos, et al. 2007 Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients BMC Cancer 7 54 10.1186/1471-2407-7-54 17389035 (Pubitemid 46554389)
28. I Papaconstantinou G Theodoropoulos M Gazouli D Panoussopoulos GJ Mantzaris E Felekouras, et al. 2005 Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population Int J Cancer 114 433 435 10.1002/ijc.20747 1:CAS:528:DC%2BD2MXhvFKksLs%3D 15578724 (Pubitemid 40279965)
29. RL Roberts RB Gearry MD Allington HR Morrin BA Robinson FA Frizelle 2006 Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer Cancer Res 66 2532 2535 10.1158/0008-5472.CAN-05-4165 1:CAS:528:DC%2BD28XhvV2htL0%3D 16510569
30. J Suchy E Klujszo-Grabowska J Kladny C Cybulski D Wokolorczyk J Szymanska-Pasternak, et al. 2008 Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk BMC Cancer 8 112 10.1186/1471-2407-8-112 18433468 (Pubitemid 351712547)
31. J Szeliga Z Sondka M Jackowski J Jarkiewicz-Tretyn A Tretyn M Malenczyk 2008 NOD2/CARD15 polymorphism in patients with rectal cancer Med Sci Monit 14 CR480 CR484 18758419
32. S Tuupanen P Alhopuro JP Mecklin H Jarvinen LA Aaltonen 2007 No evidence for association of NOD2 R702W and G908R with colorectal cancer Int J Cancer 121 76 79 10.1002/ijc.22651 1:CAS:528:DC%2BD2sXlsVajsr4%3D 17351900 (Pubitemid 46753853)
33. D Moher DJ Cook S Eastwood I Olkin D Rennie DF Stroup 1999 Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses Lancet 354 1896 1900 10.1016/S0140-6736(99)04149-5 1:STN:280:DC%2BD3c%2FkvFCgtQ%3D%3D 10584742
34. J Hampe J Grebe S Nikolaus C Solberg PJ Croucher S Mascheretti, et al. 2002 Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study Lancet 359 1661 1665 10.1016/S0140-6736(02)08590-2 1:CAS:528:DC%2BD38XjvVWjs70%3D 12020527 (Pubitemid 34518526)
35. N Inohara Y Ogura FF Chen A Muto G Nunez 2001 Human Nod1 confers responsiveness to bacterial lipopolysaccharides J Biol Chem 276 2551 2554 10.1074/jbc.M009728200 1:CAS:528:DC%2BD3MXhtVGjsLs%3D 11058605
36. Y Ogura N Inohara A Benito FF Chen S Yamaoka G Nunez 2001 Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB J Biol Chem 276 4812 4818 10.1074/jbc.M008072200 1:CAS:528: DC%2BD3MXhtlOqtL8%3D 11087742
37. F Chen V Castranova X Shi 2001 New insights into the role of nuclear factor-kappaB in cell growth regulation Am J Pathol 159 387 397 1:CAS:528:DC%2BD3MXms1WisLs%3D 11485895 (Pubitemid 32751067)
38. E Dejardin V Deregowski M Chapelier N Jacobs J Gielen MP Merville, et al. 1999 Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells Oncogene 18 2567 2577 10.1038/sj.onc.1202599 1:CAS:528:DyaK1MXjtVygtrY%3D 10353600 (Pubitemid 29216679)
39. TD Gilmore M Koedood KA Piffat DW White 1996 Rel/NF-kappaB/IkappaB proteins and cancer Oncogene 13 1367 1378 1:CAS:528:DyaK28XmsFGmsbg%3D 8875974
40. T Mukhopadhyay JA Roth SA Maxwell 1995 Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma Oncogene 11 999 1003 1:CAS:528:DyaK2MXosVyqsr8%3D 7675461
41. MA Sovak RE Bellas DW Kim GJ Zanieski AE Rogers AM Traish, et al. 1997 Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer J Clin Invest 100 2952 2960 10.1172/JCI119848 1:CAS:528: DyaK2sXotVyku7w%3D 9399940
42. T Huzarski M Lener W Domagala J Gronwald T Byrski G Kurzawski, et al. 2005 The 3020insC allele of NOD2 predisposes to early onset breast cancer Breast Cancer Res Treat 89 91 93 10.1007/s10549-004-1250-y 15666202 (Pubitemid 40228452)
43. N Rothman CF Skibola SS Wang G Morgan Q Lan MT Smith, et al. 2006 Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium Lancet Oncol 7 27 38 10.1016/S1470-2045(05)70434-4 1:CAS:528:DC%2BD28XksFOn 16389181 (Pubitemid 43025390)
44. SK Yang EV Loftus Jr WJ Sandborn 2001 Epidemiology of inflammatory bowel disease in Asia Inflamm Bowel Dis 7 260 270 10.1097/00054725-200108000-00013 1:STN:280:DC%2BD3MvntFShuw%3D%3D 11515854
45. N Inoue K Tamura Y Kinouchi Y Fukuda S Takahashi Y Ogura, et al. 2002 Lack of common NOD2 variants in Japanese patients with Crohn's disease Gastroenterology 123 86 91 10.1053/gast.2002.34155 1:CAS:528: DC%2BD38Xmt1aiu70%3D 12105836 (Pubitemid 34747528)
46. JA Cavanaugh KE Adams EJ Quak ME Bryce NJ O'Callaghan HJ Rodgers, et al. 2003 CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population Ann Hum Genet 67 35 41 10.1046/j.1469-1809.2003.00006.x 1:CAS:528:DC%2BD3sXnslKmsrk%3D 12556233 (Pubitemid 38312848)
47. V Andersen L Agerstjerne D Jensen M Ostergaard M Saebo J Hamfjord, et al. 2009 The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study BMC Med Genet 10 18 10.1186/1471-2350-10-18 19250544
48. E Giovannucci EB Rimm MJ Stampfer GA Colditz A Ascherio J Kearney, et al. 1994 A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men J Natl Cancer Inst 86 183 191 10.1093/jnci/86.3.183 1:STN:280:DyaK2c7htFWmtg%3D%3D 8283490 (Pubitemid 24042259)
49. A Ernst B Jacobsen M Ostergaard H Okkels V Andersen E Dagiliene, et al. 2007 Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population Scand J Gastroenterol 42 1445 1451 10.1080/ 00365520701427102 1:CAS:528:DC%2BD2sXht1ynu7vE 17852840 (Pubitemid 350125541)
50. RD Hansen M Sorensen A Tjonneland K Overvad H Wallin O Raaschou-Nielsen, et al. 2008 A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a Danish prospective case-cohort study BMC Cancer 8 54 10.1186/1471-2407-8-54 18289367
51. JC Anderson R Attam Z Alpern CR Messina P Hubbard R Grimson, et al. 2003 Prevalence of colorectal neoplasia in smokers Am J Gastroenterol 98 2777 2783 10.1111/j.1572-0241.2003.08671.x 14687832 (Pubitemid 38020123)
52. PS Liang TY Chen E Giovannucci 2009 Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis Int J Cancer 124 2406 2415 10.1002/ijc.24191 1:CAS:528:DC%2BD1MXltFaqt78%3D 19142968
53. P Lichtenstein NV Holm PK Verkasalo A Iliadou J Kaprio M Koskenvuo, et al. 2000 Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 78 85 10.1056/NEJM200007133430201 1:STN:280:DC%2BD3czjtFCiug%3D%3D 10891514 (Pubitemid 30451850)
54. L Aaltonen L Johns H Jarvinen JP Mecklin R Houlston 2007 Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors Clin Cancer Res 13 356 361 10.1158/1078-0432.CCR-06-1256 1:CAS:528:DC%2BD2sXotlak 17200375 (Pubitemid 46121890)
55. RS Houlston E Webb P Broderick AM Pittman MC Di Bernardo S Lubbe, et al. 2008 Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer Nat Genet 40 1426 1435 10.1038/ng.262 1:CAS:528:DC%2BD1cXhsVWhu73M 19011631
56. I Tomlinson E Webb L Carvajal-Carmona P Broderick Z Kemp S Spain, et al. 2007 A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 Nat Genet 39 984 988 10.1038/ng2085 1:CAS:528:DC%2BD2sXot1Cmsb4%3D 17618284 (Pubitemid 47185182)
57. BW Zanke CM Greenwood J Rangrej R Kustra A Tenesa SM Farrington, et al. 2007 Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24 Nat Genet 39 989 994 10.1038/ng2089 1:CAS:528:DC%2BD2sXot1Cmsb8%3D 17618283 (Pubitemid 47185183)
58. IP Tomlinson E Webb L Carvajal-Carmona P Broderick K Howarth AM Pittman, et al. 2008 A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 Nat Genet 40 623 630 10.1038/ng.111 1:CAS:528:DC%2BD1cXltFylur0%3D 18372905 (Pubitemid 351601204)
59. A Tenesa SM Farrington JG Prendergast ME Porteous M Walker N Haq, et al. 2008 Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21 Nat Genet 40 631 637 10.1038/ng.133 1:CAS:528:DC%2BD1cXltFylu7Y%3D 18372901 (Pubitemid 351601219)
60. E Jaeger E Webb K Howarth L Carvajal-Carmona A Rowan P Broderick, et al. 2008 Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk Nat Genet 40 26 28 10.1038/ng.2007.41 1:CAS:528:DC%2BD1cXhtVyruw%3D%3D 18084292
61. JN Hirschhorn K Lohmueller E Byrne K Hirschhorn 2002 A comprehensive review of genetic association studies Genet Med 4 45 61 10.1097/00125817- 200203000-00002 1:CAS:528:DC%2BD38XjtFSru7w%3D 11882781 (Pubitemid 44698579)
62. JP Ioannidis 2003 Genetic associations: false or true? Trends Mol Med 9 135 138 10.1016/S1471-4914(03)00030-3 12727138 (Pubitemid 36626701)
63. JP Ioannidis EE Ntzani TA Trikalinos DG Contopoulos-Ioannidis 2001 Replication validity of genetic association studies Nat Genet 29 306 309 10.1038/ng749 1:CAS:528:DC%2BD3MXotlWgsLs%3D 11600885 (Pubitemid 33096456)
64. QS Guo B Xia Y Jiang Y Qu J Li 2004 NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality World J Gastroenterol 10 1069 1071 1:CAS:528:DC%2BD2cXjslGhu7k%3D 15052696